0.360
-0.01 (-2.70%)
| Penutupan Terdahulu | 0.370 |
| Buka | 0.370 |
| Jumlah Dagangan | 218,135 |
| Purata Dagangan (3B) | 66,959 |
| Modal Pasaran | 45,264,292 |
| Harga / Pendapatan (P/E Ke hadapan) | 116.28 |
| Harga / Jualan (P/S) | 2.99 |
| Harga / Buku (P/B) | 1.82 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Aug 2025 - 29 Aug 2025 |
| Margin Keuntungan | -47.87% |
| Margin Operasi (TTM) | -49.16% |
| EPS Cair (TTM) | -0.130 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 43.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 19.39% |
| Nisbah Semasa (MRQ) | 3.99 |
| Aliran Tunai Operasi (OCF TTM) | -12.57 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -10.21 M |
| Pulangan Atas Aset (ROA TTM) | -16.80% |
| Pulangan Atas Ekuiti (ROE TTM) | -35.20% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (AU) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | CYCLOPHARM FPO [CYC] | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.5 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | NA |
| AI Insight | NA |
| Purata | -1.13 |
|
Cyclopharm Ltd is a health technology company offering solutions related to functional lung ventilation imaging. Its proprietary product Technegas is a broad-spectrum diagnostic lung imaging technology product for the visualisation of pulmonary ventilation and lung function. The company sells its products to healthcare institutions and medical professionals. Maximum revenue is generated from its Technegas products and services, which include the sale of diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. Geographically, the company generates maximum revenue from its business in Europe, and the rest from Asia Pacific, Canada, the USA, and other regions. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 48.68% |
| % Dimiliki oleh Institusi | 21.62% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
AI Analisis Teknikal
Buka tab Teknikal untuk menjana analisis terkini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |